July 14,2006

Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs

Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.

Next Article Previous Article

Recent News

11/20/24 Crapo Joins Fox Business to Talk Taxes
11/19/24 Crapo Statement on Announcement of Intent to Nominate Dr. Mehmet Oz to Head CMS
11/14/24 Crapo Statement on Announcement of Intent to Nominate Robert F. Kennedy Jr. to Head HHS
11/14/24 Crapo Statement at Hearing to Consider Treasury Inspector General for Tax Administration
10/30/24 Crapo, Smith Statement on Biden Administration’s Taiwan Double-Tax Relief Announcement